Shire Pharmaceuticals Group plc, Giuliani deal

SHP licensed from Giuliani worldwide development, manufacturing and marketing rights to a single dose 5-ASA mesalazine rectal foam to treat ulcerative colitis. SHPGY will seek U.S. approval and will c...